Time to Recurrence as a Prognostic Factor in Parathyroid Carcinoma

Area of Science:

• Endocrinology
• Oncology
• Surgical Pathology

Background:

• Parathyroid carcinoma (PC) is a rare endocrine malignancy with poorly defined prognostic factors.
• Understanding patient characteristics and treatment outcomes is vital for improving management strategies.

Purpose of the Study:

• To analyze the characteristics of patients treated for parathyroid carcinoma over time.
• To identify prognostic factors influencing outcomes in parathyroid carcinoma patients.

Main Methods:

• Retrospective cohort study of surgically treated parathyroid carcinoma patients (2000-2021).
• Assessment of demographic, clinical, laboratory, surgical, pathological, and follow-up data.
• Focus on free-margin resection for suspected malignancy.

Main Results:

• Seventeen patients were analyzed; 60% experienced recurrence (regional, distant, or both).
• Free margins were critical; recurrence within 36 months significantly lowered survival rates.
• Tumor staging systems and tumor size did not predict mortality; en bloc resection offered no advantage.

Conclusions:

• Parathyroid carcinoma can have an indolent course with long-term survival possible.
• Achieving free margins during initial surgery is the most critical factor for prognosis.
• Early recurrence (<36 months) is associated with poorer overall survival.